Transnational licensing, research, development, manufacturing, and commercialization agreements among life sciences businesses, institutions, and governments are essential to the life sciences industry. Demanding timelines for research, development, regulatory approval, supply, manufacturing, distribution, marketing, and sales of new biopharmaceuticals and medical devices to save and improve lives—and the enormous investments involved—make keeping these projects on course vitally important.
Opportunities for disputes exist all along these timelines. If—and when—disputes occur, they must be handled efficiently, economically, cooperatively, and confidentially.
The not-for-profit American Arbitration Association® (AAA®)-International Centre for Dispute Resolution® (ICDR®) is the largest private global provider of alternative dispute resolution (ADR) services in the world.
The AAA-ICDR’s goal—and its expertise—is to get opposing parties back to business. Its rules and expert panelists aim to lessen the cost and time spent in dispute.
In fact, in 2020, 68% of cases settled prior to an award.
AAA-ICDR is a prepared and flexible provider, as demonstrated most recently during the pandemic, when services pivoted overnight to provide parties with virtual proceedings. Virtual proceedings were not new to the AAA-ICDR, which had made this cost-effective option available to parties for years.
Life sciences ventures typically involve parties or performance across international jurisdictions, so it may be particularly important to provide for international arbitration in the contract.
The standard-bearers for a fair and successful dispute resolution are
A well-written dispute resolution clause is the foundation of an effective dispute resolution process.
In-house attorneys responsible for the contract’s dispute-resolution clause can use AAA ClauseBuilder® to that end. It is a self-guided, online process to safeguard their companies’ needs in clear, effective arbitration and mediation agreements. All elements of the clause are addressed, including expedited procedures; number, selection, and qualification of arbitrators; place and language of arbitration, and more.
The specialized life sciences panel includes international and domestic arbitrators and mediators with significant and relevant industry experience. These are attorneys admitted to the bar in one or more jurisdictions, as well as retired practitioners and industry professionals, whose practice for a minimum of 10 years has been significantly (typically 50% or more) devoted to Life Sciences (Pharmaceuticals, Biotechnology, Biomedical Technologies, or Medical Devices) and comprising, in particular, one or more or some combination of the following:
Most panel members bring hands-on experience working as litigators or transactional lawyers, either in house or as outside counsel representing businesses and institutions in the biopharmaceuticals, medical device, and related industries.
Top Caseload categories include:
Types of Disputes include:
Selected AAA-ICDR Life Sciences cases include:
For domestic life sciences inquiries: Please contact Michelle Skipper, VP, by telephone at 704.643.8605 or by email at [email protected] or fill out the form to the right.
For international life sciences inquiries: Please contact Luis M. Martinez, Esq., VP, by telephone at 212.716.5823 or by email at [email protected]. or fill out the form to the right.
Please complete the form below for more information on AAA-ICDR Life Sciences.
November 9, 2016
2:00 pm - 3:00 pm ET
AAA Panelist: $80
and Stanley Sklar
This webinar will satisfy annual
Arbitrator Continuing Education (ACE)
requirements for AAA Arbitrators.